Historical record - last NADAC effective date: 7/17/2024
Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0301 per EA under NDC 16729004515. Its NADAC has been published 158 times since Aug 11, 2021.
FDA first approved this application on Mar 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004515
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207687FDA Approved
3/30/2018
TE Code
AB
On Market Since
8/6/2018
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 158 times since Aug 11, 2021, and over the history we have for it it has declined 46.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per EA |
|---|---|
| All-time high | $0.0594 (Oct 13, 2021) |
| All-time low | $0.0301 (Jul 17, 2024) |
| Median price | $0.0420 |
| Average price | $0.0441 |
| Largest weekly change | -21.5% (Jul 17, 2024) |
| Weeks tracked | 158 |
| Tracking since | Aug 11, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-26.1%
5Y
-45.6%
All
-46.4%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0301 per EA (NDC 16729004515), effective Aug 14, 2024.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 46.4%. It has been tracked across 158 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Aug 11, 2021, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0301 (Jul 17, 2024) to a high of $0.0594 (Oct 13, 2021), with a median of $0.0420 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 20 MG TABLET, is $0.0276 per EA — about 8% below ATORVASTATIN 20 MG TABLET.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 16729004515) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.